Senior Health Home > Aflibercept

Aflibercept is a prescription drug licensed to prevent vision loss caused by a certain type of age-related macular degeneration. It is also used to treat a certain type of macular edema. This medicine comes as an injection that is given directly in the eye by a healthcare provider. Eye pain, cataracts, and eye redness are possible side effects.

What Is Aflibercept?

Aflibercept (Eylea™) is a prescription medication used to treat macular degeneration. Specifically, this drug is approved to treat a type of age-related macular degeneration called "wet" macular degeneration and to treat macular edema caused by retinal vein occlusion.
(Click What Is Aflibercept Used For? for more information on this topic, including possible off-label uses.)

Are There Side Effects?

Just like any medicine, aflibercept can cause side effects. However, not everyone who receives the drug will experience problems. Most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of aflibercept include but are not limited to:
  • Redness or blood spots on the white part of the eye
  • Eye pain
  • Cataracts.
(Click Aflibercept Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.